These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25777275)

  • 1. MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.
    Pennati M; Folini M; Gandellini P; Zaffaroni N
    Curr Drug Targets; 2016; 17(3):257-65. PubMed ID: 25777275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
    Ghafouri-Fard S; Shoorei H; Taheri M
    Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micrornas in prostate cancer: an overview.
    Vanacore D; Boccellino M; Rossetti S; Cavaliere C; D'Aniello C; Di Franco R; Romano FJ; Montanari M; La Mantia E; Piscitelli R; Nocerino F; Cappuccio F; Grimaldi G; Izzo A; Castaldo L; Pepe MF; Malzone MG; Iovane G; Ametrano G; Stiuso P; Quagliuolo L; Barberio D; Perdonà S; Muto P; Montella M; Maiolino P; Veneziani BM; Botti G; Caraglia M; Facchini G
    Oncotarget; 2017 Jul; 8(30):50240-50251. PubMed ID: 28445135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and prostate cancer.
    Pang Y; Young CY; Yuan H
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in prostate cancer: Practical aspects.
    Patil PA; Magi-Galluzzi C
    Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.
    Bascetta L; Oliviero A; D'Aurizio R; Evangelista M; Mercatanti A; Pellegrini M; Marrocolo F; Bracarda S; Rizzo M
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor and miR-206 regulation in prostate cancer.
    Chua FY; Adams BD
    Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Kingdom Gene regulation via miRNAs of Hypericum perforatum (St. John's wort) flower dietetically absorbed: An in silico approach to define potential biomarkers for prostate cancer.
    Ergün S
    Comput Biol Chem; 2019 Jun; 80():16-22. PubMed ID: 30861403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.